Primary Care Pathology Services

Tender description

NHS Suffolk and North East Essex Integrated Care Board have reviewed pathology services delivered within the Suffolk and North East Essex Integrated Care System. The ICB has awarded the contract for the delivery of these services to NHS West Suffolk NHS Foundation Trust and East Suffolk and North Essex NHS Foundation Trust working together to deliver Pathology needs within SNEE ICB. East Suffolk and North Essex NHS Foundation Trust and NHS West Suffolk NHS Foundation Trust will be awarded the contracts as they are uniquely placed to continue to deliver the primary care pathology services for the locality. The acute trusts have an integrated provision which includes delivery of pathology services for all acute divisions, community services and primary care. It is believed that retaining this configuration is in the best interest of the patients and the Integrated Care System. Lot 1: This notice is made by the Contracting Authority; NHS Suffolk and North East Essex Integrated Care Board (hereinafter referred to as "the Authority") in compliance with their local standing financial instructions (SFIs) to notify the market of the award of a contract to deliver a Primary Care Pathology Service to NHS West Suffolk NHS Foundation Trust and East Suffolk and North Essex NHS Foundation Trust. The total contract value is forecasted to be £34,000,000 over the two year term (excluding VAT). NHS West Suffolk NHS Foundation Trust will receive a contract over two (2) years with a total value of £13,800,000. East Suffolk and North Essex NHS Foundation Trust will receive a contract over two (2) years with a total value of £20,400,000. The two year contract will start on the 1st April 2023, ending on the 31st March 2025. The Contracting Authority is yet to agree appropriate inflation and uplift for this contract for the period of 2023/24 through to 2024/25. These will be dealt with as Contract Variations in accordance with the NHS Standard Contract Terms and Conditions. The Authority deems any such variations are not substantial or material changes, as they occur due to external causes beyond the Authority's control, including changes in contract value driven by changes in patient volume. The Authority will publish appropriate Notices accordingly to communicate any such future changes to the market, once final. The Authority is to retain the provision within the Acute Trusts named in this notice to ensure the following risks (list is not exhaustive) are not realised: -Clinical risks of involving different clinical IT systems within one pathology system - negative impact on patient safety -Clinical risks and cost brought about from duplicate tests -Reduction in economies of scale when integrated care systems are tasked with being more efficient. -Risk of losing skilled staff or needing more skilled staff across multiple providers when recruitment for skilled pathology staff is difficult. -Destabilising the core pathology function within the acute Trusts Additional information: The Service to which this procurement relates fall within Schedule 3 of the Public Contracts Regulations 2015 as amended by as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020, (the "Regulations"). As such, the Contracting Authority does not intend to hold itself bound by any of the Regulations, save those applicable to Schedule 3 Services.